EUVIMEDEUVIMED entdecken
Crossref

Diagnostic evaluation of upper tract urothelial carcinoma: can we safely omit diagnostic ureteroscopy?

Matthew Trail iD, Muhammad Sajid Waheed Rahman, William J Broadhurst, James P Blackmur iD, Abhishek Sharma, Etienne Chew, Marie O'Donnell, Julian Y Keanie, John Brush, John Taylor, Simon Phipps, Ben Thomas und 5 weitere

BJU International · 2023-06 · 131 (6) · 755-762

DOI: 10.1111/bju.15945 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BJU International, online erschienen am 23.01.2023. Verfasst von Matthew Trail und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Western General Hospital, Edinburgh, UK. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Ureteral Neoplasms, Kidney Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To identify clinicopathological or radiological factors that may predict a diagnosis of upper urinary tract urothelial cell carcinoma (UTUC) to inform which patients can proceed directly to radical nephroureterectomy (RNU) without the delay for diagnostic ureteroscopy (URS). Patients and Methods All consecutive patients investigated for suspected UTUC in a high‐volume UK centre between 2011 and 2017 were identified through retrospective analysis of surgical logbooks and a prospectively maintained pathology database. Details on clinical presentation, radiological findings, and URS/RNU histopathology results were evaluated. Multivariate regression analysis was performed to evaluate predictors of a final diagnosis of UTUC.

Results

In all, 260 patients were investigated, of whom 230 (89.2%) underwent URS. RNU was performed in 131 patients (50.4%), of whom 25 (9.6%) proceeded directly without URS – all of whom had a final histopathological diagnosis of UTUC – and 15 (11.5%) underwent RNU after URS despite no conclusive histopathological confirmation of UTUC. Major surgery was avoided in 77 patients (33.5%) where a benign or alternative diagnosis was made on URS, and 14 patients (6.1%) underwent nephron‐sparing surgery. Overall, 178 patients (68.5%) had a final diagnosis of UTUC confirmed on URS/RNU histopathology. On multivariate logistic regression analysis, a presenting complaint of visible haematuria (hazard ratio [HR] 5.17, confidence interval [CI] 1.91–14.0; P = 0.001), a solid lesion reported on imaging (HR 37.8, CI = 11.7–122.1; P < 0.001) and a history of smoking (HR 3.07, CI 1.35–6.97; P = 0.007), were predictive of a final diagnosis of UTUC. From this cohort, 51 (96.2%) of 53 smokers who presented with visible haematuria and who had a solid lesion on computed tomography urogram had UTUC on final histopathology.

Conclusion

We identified specific factors which may assist clinicians in selecting which patients may reliably proceed to RNU without the delay of diagnostic URS. These findings may inform a prospective multicentre analysis including additional variables such as urinary cytology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsCarcinoma, Transitional CellUreteral NeoplasmsKidney NeoplasmsHumansUreteroscopyHematuriaRetrospective StudiesProspective Studies

Stichwörter der Autor:innen

#uroonc#utucCT urographyUTUCUUTUCdiagnosisdiagnostic ureteroscopypathwayupper urinary tract urothelial cell carcinoma

Autor:innen und Institutionen

  • Department of Urology, Western General Hospital, Edinburgh, UK.
  • College of Medicine and Veterinary Medicine, The University of Edinburgh, Edinburgh, UK.
  • Centre for Genomic & Experimental Medicine, Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh, UK.
  • Department of Histopathology, Western General Hospital, Edinburgh, UK.
  • Department of Radiology, Western General Hospital, Edinburgh, UK.

ORCID-Profile: Matthew Trail, James P Blackmur, Edward A A Mains, Alexander Laird

Zitieren

APA

Trail, M., Rahman, M. S. W., Broadhurst, W. J., Blackmur, J. P., Sharma, A., Chew, E., O'Donnell, M., Keanie, J. Y., Brush, J., Taylor, J., Phipps, S., Thomas, B., Mains, E. A. A., McNeill, S. A., Leung, S., Cutress, M. L., & Laird, A. (2023). Diagnostic evaluation of upper tract urothelial carcinoma: can we safely omit diagnostic ureteroscopy?. BJU International, 131(6), 755-762. https://doi.org/10.1111/bju.15945

Vancouver

Trail M, Rahman MSW, Broadhurst WJ, Blackmur JP, Sharma A, Chew E, et al. Diagnostic evaluation of upper tract urothelial carcinoma: can we safely omit diagnostic ureteroscopy?. BJU International. 2023;131(6):755-762. doi:10.1111/bju.15945

BibTeX
@article{Trail2023,
  author = {Trail, Matthew and Rahman, Muhammad Sajid Waheed and Broadhurst, William J and Blackmur, James P and Sharma, Abhishek and Chew, Etienne and O'Donnell, Marie and Keanie, Julian Y and Brush, John and Taylor, John and Phipps, Simon and Thomas, Ben and Mains, Edward A A and McNeill, S Alan and Leung, Steve and Cutress, Mark L and Laird, Alexander},
  title = {Diagnostic evaluation of upper tract urothelial carcinoma: can we safely omit diagnostic ureteroscopy?},
  journal = {BJU International},
  year = {2023},
  volume = {131},
  number = {6},
  pages = {755--762},
  doi = {10.1111/bju.15945}
}
Kostenlos starten →